JRJosé Ernesto Ramírez-González

José Ernesto Ramírez-González

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


José Ernesto Ramírez-González has a total of 190 co-authors. Here are the top co-authors by number of shared publications:

  • José Alberto Díaz-Quiñonez

    Univ Nacl Autonoma Mexico, Fac Med, Div Estudios Posgrad, Mexico City, DF, Mexico

    11 shared publications
  • Noé Escobar-Escamilla

    Instituto de Diagnóstico y Referencia Epidemiológicos, Secretaría de Salud, Francisco de P Miranda 177, Lomas de Plateros, Álvaro Obregón, Mexico City 01480, Mexico

    9 shared publications
  • Lucía Hernández-Rivas

    Instituto de Diagnóstico y Referencia Epidemiológicos (InDRE) “Dr. Manuel Martínez Báez”, Secretaría de Salud, Mexico City, Mexico

    8 shared publications
  • Fabiola Garcés-Ayala

    Instituto de Diagnóstico y Referencia Epidemiológicos (InDRE) “Dr. Manuel Martínez Báez”, Secretaría de Salud, Mexico City, Mexico

    7 shared publications
  • Irma López-Martínez

    Dirección General de Epidemiología, Instituto de Diagnóstico y Referencia Epidemiológicos “Dr. Manuel Martínez Báez, Mexico City, Mexico

    7 shared publications
  • Gisela Barrera-Badillo

    Institute of Epidemiological Diagnosis and Reference, InDRE, Mexico City 01480, Mexico

    6 shared publications

Latest Publications

  • Open Access

    Convergent trends and spatiotemporal patterns of arboviruses in Mexico and Central America

    by Bernardo Gutierrez, Darlan da Silva Candido, Sumali Bajaj, Abril Paulina Rodriguez Maldonado, Fabiola Garces Ayala, María de la Luz Torre Rodriguez, Adnan Araiza Rodriguez, Claudia Wong Arámbula, Ernesto Ramírez González, Irma López Martínez, et al.

    Background Arboviruses cause both seasonal epidemics (e.g. dengue viruses, DENV) and emerging outbreaks (e.g. chikungunya and Zika viruses, CHIKV and ZIKV) with a significant impact on global health. These viruses share mosquito vector species, often infecting the same host population within overlapping geographic regions. Thus, comparative analyses of their evolutionary and epidemiological dynamics across spatial and temporal scales could reveal convergent transmission trends. Methodology/Principal Findings Focusing on Mexico as a case study, we generated CHIKV, DENV-1 and DENV-2 genomes from an epidemiological surveillance-derived historical sample collection, and analysed them together with longitudinally-collected genome and epidemiological data from the Americas. Arboviruses endemically circulating within the country were found to be introduced multiple times from lineages predominantly sampled from the Caribbean and Central America. For CHIKV, at least thirteen introductions were inferred over a year, with six of these leading to persistent transmission chains. For both DENV-1 and DENV-2, at least seven introductions were inferred over a decade. Conclusions/Significance Our results suggest that CHIKV, DENV-1 and DENV-2 in Mexico share similar evolutionary and epidemiological trajectories. The southwest region of the country was determined to be the most likely location for viral introductions from abroad, with a subsequent spread into the Pacific coast towards the north of Mexico. The virus diffusion patterns observed across the country are likely driven by multiple factors, including mobility linked to human migration from Central towards North America. Considering Mexico‘s economic role and geographic positioning displaying a high human mobility across borders, our results prompt the need to better understand the role of anthropogenic factors in the transmission dynamics of arboviruses, particularly linked to land-based human migration. AUTHOR SUMMARY Mexico is endemic to several mosquito-borne viruses relevant to global health, and ranks within the top five countries in the Americas that report the highest case numbers. Our study provides a general overview of arbovirus introduction, spread and establishment patterns in North and Central America, and should be of interest to both local health and global authorities. Moreover, it sets to explore the paradigm of convergence at different scales in independent virus populations, represented by comparable epidemiological and evolutionary trends in arboviruses sharing ecological niches. Our results represent important advances in the study of mosquito-borne viruses listed as a threat to global health, specifically applied to key countries within the developing world


  • Analysis of the genomic diversity of human papillomavirus type 31 in cervical samples reveals the presence of novel sublineages in clade C

    by David Esaú Fragoso-Fonseca, Ubaldo Emilio Ruiz-Hernández, Brenda Berenice Trujillo-Salgado, Rita Teresita Manuell-Barrios, Fabiola Garcés-Ayala, Juan Carlos del Mazo-López, Alfonso Méndez-Tenorio, Lucía Hernández-Rivas, José Ernesto Ramírez-González, Noé Escobar-Escamilla

    Human papillomavirus 31 (HPV31) is the fourth most frequent high-risk HPV (HR-HPV) genotype identified in cervical cancer (CC) worldwide and in Mexico. It has been recently classified into three lineages (A, B, and C) and eight sublineages (A1, A2, B1, B2, and C1 – C4). Here, we report the complete genomic sequences of 14 HPV31 isolates from cervical samples, and these were compared with viral genome sequences from the GenBank database for phylogenetic and genetic distance analysis. The formation of two novel clades within the C lineage (proposed as C5 and C6) was observed, with a well-defined variant-specific mutational pattern. The smallest average pairwise distance was 0.71% for lineages A and B, 0.94% for lineages A and C, and 1.01% for lineages B and C, and between sublineages, these values were 0.21% for clade A, 0.29% for clade B, and 0.24% for clade C. The isolates were grouped into the sublineages A1, B2, C1-C3, and C6. This is the first report on the whole-genome diversity of HPV31 in Mexico.


  • Open Access

    Genetic Analysis of SARS-CoV-2 Variants in Mexico during the First Year of the COVID-19 Pandemic

    by Blanca Taboada, Selene Zárate, Pavel Iša, Celia Boukadida, Joel Armando Vazquez-Perez, José Esteban Muñoz-Medina, José Ernesto Ramírez-González, Andreu Comas-García, Concepción Grajales-Muñiz, Alma Rincón-Rubio, et al.

    During the first year of the SARS-CoV-2 pandemic in Mexico, more than two million people were infected. In this study, we analyzed full genome sequences from 27 February 2020 to 28 February 2021 to characterize the geographical and temporal distribution of SARS-CoV-2 lineages and identify the most common circulating lineages during this period. We defined six different geographical regions with particular dynamics of lineage circulation. The Northeast and Northwest regions were the ones that exhibited the highest lineage diversity, while the Central south and South/Southeast regions presented less diversity with predominance of a certain lineage. Additionally, by late February 2021, lineage B.1.1.519 represented more than 89% of all circulating lineages in the country.


  • Emergence and spread of the potential variant of interest (VOI) B.1.1.519 of SARS-CoV-2 predominantly present in Mexico

    by Abril Paulina Rodríguez-Maldonado, Joel Armando Vázquez-Pérez, Alberto Cedro-Tanda, Blanca Taboada, Celia Boukadida, Claudia Wong-Arámbula, Tatiana Ernestina Nuñez-García, Natividad Cruz-Ortiz, Gisela Barrera-Badillo, Lucía Hernández-Rivas, et al.

    SARS-CoV-2 variants emerged in late 2020, and at least three variants of concern (B.1.1.7, B.1.351, and P1) have been reported by WHO. These variants have several substitutions in the spike protein that affect receptor binding; they exhibit increased transmissibility and may be associated with reduced vaccine effectiveness. In the present work, we report the identification of a potential variant of interest, harboring the mutations T478K, P681H, and T732A in the spike protein, within the newly named lineage B.1.1.519, that rapidly outcompeted the preexisting variants in Mexico and has been the dominant virus in the country during the first trimester of 2021.


  • Open Access

    Emergence and spread of the potential variant of interest (VOI) B.1.1.519 predominantly present in Mexico

    by Abril Paulina Rodríguez-Maldonado, Joel Armando Vázquez-Pérez, Alberto Cedro-Tanda, Blanca Taboada, Celia Boukadida, Claudia Wong-Arámbula, Tatiana Ernestina Nuñez-García, Natividad Cruz-Ortiz, Gisela Barrera-Badillo, Lucía Hernández-Rivas, et al.

    SARS-CoV-2 variants have emerged in late 2020 and there are at least three variants of concern (B.1.1.7, B.1.351, P1) reported by WHO. These variants have several substitutions in the Spike protein that affect receptor binding; they present increased transmissibility and may be associated with reduced vaccine effectiveness. In the present work, we are reporting the identification of a potential variant of interest harboring the mutations T478K, P681H, and T732A in the Spike protein, within the newly named lineage B.1.1.519, which rapidly outcompeted the preexisting variants in Mexico and has been the dominant virus in the country during the first trimester of 2021.


  • Epidemiological surveillance of chikungunya fever in Mexico since its introduction in 2014–2016 and identification of circulating genotypes

    by Belem Torres-Longoria, David Esaú Fragoso-Fonseca, Alma Núñez-León, María de la Luz Torres, Mauricio Vázquez-Pichardo, Noé Escobar-Escamilla, Claudia Wong-Arámbula, José Ernesto Ramírez-González, Alfonso Méndez-Tenorio, María Eugenia Castro-Mussot, et al.

    In 2014, the chikungunya virus (CHIKV) was detected for the first time in Mexico, the identified strain was the one corresponding to the Asian genotype which was phylogenetically grouped with the strains that circulated in the British Virgin Islands outbreak and was later classified with lineages of Caribbean strains. In three years, 13,569 cases of chikungunya were registered in Mexico. Although the transmission and spread of the virus are now considered a moderate risk, the danger that the virus reemerges is not ruled out due to the infestation of Aedes mosquitoes. In this study, we reviewed the chikungunya fever (CHIKF) cases reported between 2014 and 2016 to reanalyze the data. Seventeen cases were selected from different states where the circulation of the virus had been reported. Statistical data were analyzed and a retrospective analysis was carried out. Nucleic acid sequences were determined of these 17 samples. 2015 was the year with the highest number of cases (92.8%) and they were detected in 28 states of the country. There is a predominance of females, and the most affected age group was between 25 and 44 years. In 2016, CHIKV genotypes were not known, in this study the presence of the Asian genotype of Caribbean lineage was confirmed. The presence of the West African and ECSA genotypes was phylogenetically ruled out. The sequences obtained were deposited in GeneBank.


  • Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico

    by Blanca Taboada, Joel Armando Vazquez-Perez, José Esteban Muñoz-Medina, Pilar Ramos-Cervantes, Marina Escalera-Zamudio, Celia Boukadida, Alejandro Sanchez-Flores, Pavel Isa, Edgar Mendieta-Condado, José A. Martínez-Orozco, et al.

    Understanding the introduction, spread, and establishment of SARS-CoV-2 within distinct human populations as well as the evolution of the pandemics is crucial to implement effective control strategies. In this work, we report that the initial virus strains introduced in Mexico came from Europe and the United States and that the virus was circulating locally in the country as early as mid-March. We also found evidence for early local transmission of strains with a H49Y mutation in the Spike protein, which could be further used as a molecular marker to follow viral spread within the country and the region.


  • Open Access

    Full genome sequence of the first SARS-CoV-2 detected in Mexico

    by Fabiola Garcés-Ayala, Adnan Araiza-Rodríguez, Edgar Mendieta-Condado, Abril Paulina Rodríguez-Maldonado, Claudia Wong-Arámbula, Magaly Landa-Flores, Juan Carlos del Mazo-López, Maribel González-Villa, Noé Escobar-Escamilla, David Esaú Fragoso-Fonseca, et al.

    SARS-CoV-2 was first detected in the city of Wuhan, Hubei Province, China. In this report, we describe the complete genome sequence of the first imported SARS-CoV-2, detected in a Mexican patient who had traveled to Bergamo, Italy. Phylogenetic analysis showed that this isolate belongs to subclade A2a (lineage G) and is closely related to isolates from Finland, Germany and Brazil, all of which were from patients with a history of travel to Italy. This is the first report of the complete genome sequence of this virus in Mexico.


  • Open Access

    Genomic analysis of early SARS-CoV-2 strains introduced in Mexico

    by Blanca Taboada, Joel Armando Vazquez-Perez, José Esteban Muñoz Medina, Pilar Ramos Cervantes, Marina Escalera-Zamudio, Celia Boukadida, Alejandro Sanchez-Flores, Pavel Isa, Edgar Mendieta Condado, José Arturo Martínez-Orozco, et al.

    The COVID-19 pandemic has affected most countries in the world. Studying the evolution and transmission patterns in different countries is crucial to implement effective strategies for disease control and prevention. In this work, we present the full genome sequence for 17 SARS-CoV-2 isolates corresponding to the earliest sampled cases in Mexico. Global and local phylogenomics, coupled with mutational analysis, consistently revealed that these viral sequences are distributed within 2 known lineages, the SARS-CoV-2 lineage A/G, containing mostly sequences from North America, and the lineage B/S containing mainly sequences from Europe. Based on the exposure history of the cases and on the phylogenomic analysis, we characterized fourteen independent introduction events. Additionally, three cases with no travel history were identified. We found evidence that two of these cases represent local transmission cases occurring in Mexico during mid-March 2020, denoting the earliest events described in the country. Within this Mexican cluster, we also identified an H49Y amino acid change in the spike protein. This mutation is a homoplasy occurring independently through time and space, and may function as a molecular marker to follow on any further spread of these viral variants throughout the country. Our results depict the general picture of the SARS-CoV-2 variants introduced at the beginning of the outbreak in Mexico, setting the foundation for future surveillance efforts. This work is the result of the collaboration of five institutions into one research consortium: three public health institutes and two universities. From the beginning of this work, it was agreed that the experimental leader of each institution would share the first authorship. Those were the criteria followed to assign first co-first authorship in this manuscript. The order of the other authors was randomly assigned. IMPORTANCE: Understanding the introduction, spread and establishment of SARS-CoV-2 within distinct human populations is crucial to implement effective control strategies as well as the evolution of the pandemics. In this work, we describe that the initial virus strains introduced in Mexico came from Europe and the United States and the virus was circulating locally in the country as early as mid-March. We also found evidence for early local transmission of strains having the mutation H49Y in the Spike protein, that could be further used as a molecular marker to follow viral spread within the country and the region.


  • Complete genome sequence of a coxsackievirus type A24 variant causing an outbreak of acute haemorrhagic conjunctivitis in southeastern Mexico in 2017

    by David Esaú Fragoso-Fonseca, Noé Escobar-Escamilla, Abril Paulina Rodríguez-Maldonado, Gisela Barrera-Badillo, Fabiola Garcés-Ayala, Edgar Mendieta-Condado, Elizabeth González-Durán, Fernando I. Puerto, Lucía Hernández-Rivas, Irma López-Martínez, et al.

    Cases of acute haemorrhagic conjunctivitis (AHC) caused by a coxsackie virus A24 variant (CV-A24v) in Mexico have been reported since 1987; however, no molecular data on the causative strains have been available. Here, we report the identification of the etiological agent responsible for the most recent AHC outbreak in southeastern Mexico (at the end of 2017) as well as the complete genome sequences of seven isolates, using next-generation sequencing (NGS). Phylogenomic analysis of the CV-A24v sequences reported here showed similarity to contemporary strains causing AHC outbreaks in French Guiana and Uganda, forming a novel clade related to genotype IV. Moreover, a specific mutational pattern in the non-structural proteins was identified in the 2017 isolates. This is the first report of genetic characterization of CV-A24v isolates obtained in Mexico.